跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mediquet 50 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mediquet 50
Approved
STANDARD
Mediquet 50
Cubit Lifesciences LLP
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
655e3321cce5e69c
Company
Cubit Lifesciences LLP
Type
Standard
Approval Details
Approval Id
655e3321cce5e69c
Drug Approval Philippines Name
Mediquet 50
Product Name
Mediquet 50
Registration Number
DRP-15857
Brand Name
Mediquet 50
Generic Name
Quetiapine (as fumarate)
Dosage Form
Extended-Release Tablet
Dosage Strength
50 mg
Manufacturer
Cubit Lifesciences LLP
Importer
Medinova Pharmaceutical Inc.
Distributor
Medinova Pharmaceutical Inc.
Issuance Date
24 September 2024
Expiry Date
24 September 2029
Pharmacologic Category
Antipsychotic (Diazepines, Oxazipines, and Oxepines)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
655e3321cce5e69c
Type
Standard
Back to Philippines FDA Approvals